54 results
8-K
EX-99.1
mgkepg7ktunc
29 Mar 24
Results of Operations and Financial Condition
8:35am
8-K
EX-99.1
9odp30
9 Jan 24
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002
8:11am
8-K
EX-99.1
bxnn9xaqfg
9 Nov 23
Results of Operations and Financial Condition
4:41pm
8-K/A
EX-99.2
efdkz4oodz
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
8-K/A
EX-99.3
yaas6k
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
8-K/A
EX-99.1
necj uv91ms
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
8-K
EX-99.1
31mleuxusjis0l
11 Aug 23
Elicio Therapeutics Reports Second Quarter 2023 Financial Results and Provides
11:42am
8-K
EX-10.2
uoovvhk6l0rlb7 48e7a
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.5
zvta6k5a
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.3
jbialv6pl
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.4
c9yk6kf nfpx1mmfh
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
424B3
3gi1ajy2uilt2fw1kh26
28 Apr 23
Prospectus supplement
4:07pm